Erin Crane to Paclitaxel
This is a "connection" page, showing publications Erin Crane has written about Paclitaxel.
Connection Strength
0.404
-
Brown J, Miller A, Holman LL, Backes F, Nagel C, Bender D, Miller DS, Powell MA, Westin SN, Bonebrake A, Muller CY, Secord AA, Crane E, Schorge J, Tew WP, Sood AK, Bookman MA, Aghajanian C, Gershenson DM. Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14. Gynecol Oncol. 2024 Nov; 190:283-290.
Score: 0.216
-
Crane E. Beyond Serous: Treatment Options for Rare Endometrial Cancers. Curr Treat Options Oncol. 2022 Nov; 23(11):1590-1600.
Score: 0.189